TY - JOUR
T1 - Characteristics of long-COVID among older adults
T2 - a cross-sectional study
AU - ESCMID Study Group for Infections in the Elderly (ESGIE)
AU - Daitch, Vered
AU - Yelin, Dana
AU - Awwad, Muhammad
AU - Guaraldi, Giovanni
AU - Milić, Jovana
AU - Mussini, Cristina
AU - Falcone, Marco
AU - Tiseo, Giusy
AU - Carrozzi, Laura
AU - Pistelli, Francesco
AU - Nehme, Mayssam
AU - Guessous, Idris
AU - Kaiser, Laurent
AU - Vetter, Pauline
AU - Bordas-Martínez, Jaume
AU - Durà-Miralles, Xavier
AU - Peleato-Catalan, Dolores
AU - Gudiol, Carlota
AU - Shapira-Lichter, Irit
AU - Abecasis, Donna
AU - Leibovici, Leonard
AU - Yahav, Dafna
AU - Margalit, Ili
N1 - Publisher Copyright:
© 2022
PY - 2022/12
Y1 - 2022/12
N2 - Objectives: To describe long-COVID symptoms among older adults and to assess the risk factors for two common long-COVID symptoms: fatigue and dyspnea. Methods: This is a multicenter, prospective cohort study conducted in Israel, Switzerland, Spain, and Italy. Individuals were included at least 30 days after their COVID-19 diagnosis. We compared long-COVID symptoms between elderly (aged >65 years) and younger individuals (aged 18-65 years) and conducted univariate and multivariable analyses for the predictors of long-COVID fatigue and dyspnea. Results: A total of 2333 individuals were evaluated at an average of 5 months (146 days [95% confidence interval 142-150]) after COVID-19 onset. The mean age was 51 years, and 20.5% were aged >65 years. Older adults were more likely to be symptomatic, with the most common symptoms being fatigue (38%) and dyspnea (30%); they were more likely to complain of cough and arthralgia and have abnormal chest imaging and pulmonary function tests. Independent risk factors for long-COVID fatigue and dyspnea included female gender, obesity, and closer proximity to COVID-19 diagnosis; older age was not an independent predictor. Conclusion: Older individuals with long-COVID have different persisting symptoms, with more pronounced pulmonary impairment. Women and individuals with obesity are at risk. Further research is warranted to investigate the natural history of long-COVID among the elderly population and to assess possible interventions aimed at promoting rehabilitation and well-being.
AB - Objectives: To describe long-COVID symptoms among older adults and to assess the risk factors for two common long-COVID symptoms: fatigue and dyspnea. Methods: This is a multicenter, prospective cohort study conducted in Israel, Switzerland, Spain, and Italy. Individuals were included at least 30 days after their COVID-19 diagnosis. We compared long-COVID symptoms between elderly (aged >65 years) and younger individuals (aged 18-65 years) and conducted univariate and multivariable analyses for the predictors of long-COVID fatigue and dyspnea. Results: A total of 2333 individuals were evaluated at an average of 5 months (146 days [95% confidence interval 142-150]) after COVID-19 onset. The mean age was 51 years, and 20.5% were aged >65 years. Older adults were more likely to be symptomatic, with the most common symptoms being fatigue (38%) and dyspnea (30%); they were more likely to complain of cough and arthralgia and have abnormal chest imaging and pulmonary function tests. Independent risk factors for long-COVID fatigue and dyspnea included female gender, obesity, and closer proximity to COVID-19 diagnosis; older age was not an independent predictor. Conclusion: Older individuals with long-COVID have different persisting symptoms, with more pronounced pulmonary impairment. Women and individuals with obesity are at risk. Further research is warranted to investigate the natural history of long-COVID among the elderly population and to assess possible interventions aimed at promoting rehabilitation and well-being.
KW - COVID-19
KW - Long-COVID
KW - Long-lasting symptoms
KW - Older adults
KW - Post-COVID-19
KW - SARS-CoV-2
UR - http://www.scopus.com/inward/record.url?scp=85144589410&partnerID=8YFLogxK
U2 - 10.1016/j.ijid.2022.09.035
DO - 10.1016/j.ijid.2022.09.035
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 36191820
AN - SCOPUS:85144589410
SN - 1201-9712
VL - 125
SP - 287
EP - 293
JO - International Journal of Infectious Diseases
JF - International Journal of Infectious Diseases
ER -